Paul Tudor Jones X Biotech Inc. Transaction History

Tudor Investment Corp Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$6.86 - $10.46 $92,904 - $141,659	-13,543 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.99 - $11.27 $13,623 - $21,965	-1,949 Reduced 12.58%	13,543 $103,000
Q1 2019 May 15, 2019	SELL	$5.05 - $11.62 $28,916 - $66,536	-5,726 Reduced 26.99%	15,492 $171,000
Q3 2017 Nov 14, 2017	BUY	$4.14 - $5.12 $87,842 - $108,636	21,218	21,218 $93,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $224M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.